Showing all 11 results
Amantidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Immediate-Release Tablet, packed in moisture-resistant Alu-Alu or Alu-PVC blister strips.
Active Ingredient Strength Primary Clinical Function Amantadine Hydrochloride USP/BP 100 mg The Standard Therapeutic Anchor: The globally validated dose for both Parkinsonian motor control and antiviral prophylaxis. Excipients Proprietary Matrix Rapid-Release System: Engineered to ensure a consistent $T_{max}$ (peak concentration) of approx. 2 to 4 hours for reliable daily protection. Darifenacin Prolonged Release Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Prolonged-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Darifenacin Hydrobromide USP/Ph.Eur.
(Equivalent to Darifenacin base)7.5 mg (PR) The Standard Titration & Geriatric Anchor: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients to control OAB symptoms with minimal side effects. Darifenacin Hydrobromide USP/Ph.Eur. 15 mg (PR) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for patients who require greater symptom relief and have demonstrated high tolerability to the 7.5 mg dose. Excipients Hypromellose (HPMC) / Dibasic Calcium Phosphate / Magnesium Stearate / Polyethylene Glycol / Titanium Dioxide / Premium Polymeric Film Hydrophilic PR Matrix / Diluent / Lubricant / Plasticizer / Opaque Film (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastrointestinal fluids, the tablet hydrates to form a thick, gelatinous outer layer that strictly controls the diffusion of the highly soluble hydrobromide salt over a 24-hour period) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urological dispensing regimens).
Mirabegron Extended-Release Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix ER Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute physical stability of the extended-release polymers.
Active Ingredient Strength Primary Clinical Function Mirabegron Ph.Eur./USP 25 mg (ER) Initiation / Renal Standard: Base therapeutic unit for assessing patient tolerance and for use in patients with severe renal or hepatic impairment. Mirabegron Ph.Eur./USP 50 mg (ER) Global Urology Standard: High-efficacy adult maintenance therapy for maximum suppression of urge urinary incontinence and detrusor overactivity. Excipients Polyethylene Oxide / Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Magnesium Stearate / Premium Opadry Film Swellable ER Polymer / Hydrophilic Matrix Base / Antioxidant / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the active ingredient over 24 hours) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urology dispensing regimens).
Oxybutynin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE desiccant bottles to ensure the absolute chemical stability of the controlled-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Oxybutynin Chloride USP/Ph.Eur. 5 mg (ER) Initiation Standard: Base once-daily titration unit for the gradual introduction of antimuscarinic therapy. Oxybutynin Chloride USP/Ph.Eur. 10 mg / 15 mg (ER) Global Clinical Standard: Advanced maintenance doses for severe, refractory Overactive Bladder and neurogenic detrusor overactivity. Excipients Hypromellose (HPMC) / Lactose Anhydrous / Macrogol (PEG) / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Diluent / Plasticizer / Premium Film-Coating (Engineered specifically to form a highly viscous external gel barrier upon swallowing, controlling the exact 24-hour drug diffusion rate) *Pack Sizes: Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 30-day chronic urology dispensing regimens).
Piracetam Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-gauge PVC/PVDC blister strips to ensure the absolute chemical stability of the highly hygroscopic API.
Active Ingredient Strength Primary Clinical Function Piracetam Ph.Eur./USP 400 mg Initiation / Pediatric Standard: Base unit for pediatric dyslexia and mild vertigo management. Piracetam Ph.Eur./USP 800 mg Global Cognitive Standard: Standard adult maintenance dose for age-related cognitive decline and memory impairment. Piracetam Ph.Eur./USP 1200 mg Acute Neurology Standard: Massive-dose unit designed specifically for Cortical Myoclonus and intensive post-stroke rehabilitation protocols to minimize pill burden. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Macrogol (PEG) / Colloidal Silicon Dioxide / Magnesium Stearate High-Density Diluent / Superdisintegrant / Premium Film-Coating (Engineered specifically to compress the massive API load into a smooth, swallowable, moisture-resistant oblong tablet) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, high-volume chronic neurology dispensing where patients may consume 2.4g to 4.8g daily).
Solifenacin Succinate Tablets
FreeA Solifenacin Succinate tablet is an antimuscarinic (anticholinergic) medication used to treat symptoms of an overactive bladder, such as frequent or urgent urination and urinary incontinence.
Tamsulosin & Dutasteride Capsules
FreeTamsulosin and dutasteride capsules are a combination therapy used to treat moderate to severe symptoms of benign prostatic hyperplasia (BPH). They are most commonly available in a fixed-dose strength of 0.4 mg tamsulosin hydrochloride and 0.5 mg dutasteride.
Tamsulosin 0.4 Mg + Dutasteride 0.5 Mg Tablets
FreeA tablet or capsule containing Tamsulosin 0.4 mg + Dutasteride 0.5 mg is a dual-action combination medication used to treat moderate to severe symptoms of Benign Prostatic Hyperplasia (BPH), or an enlarged prostate.
Tamsulosin 0.4 mg tablet
FreeA Tamsulosin 0.4 mg tablet (or capsule) is a selective alpha-1 adrenergic receptor antagonist used to treat symptoms of an enlarged prostate, also known as Benign Prostatic Hyperplasia (BPH).
Tamsulosin 0.4Mg + Finasteride 5Mg Tablet
FreeA Tamsulosin 0.4mg + Finasteride 5mg tablet is a combination medication used to manage Benign Prostatic Hyperplasia (BPH), also known as an enlarged prostate. This dual therapy is designed to provide both rapid symptom relief and long-term reduction of prostate size.
Tamsulosin Capsules
FreeTamsulosin capsules are selective alpha-blocker medications used to treat symptoms of an enlarged prostate (Benign Prostatic Hyperplasia). They are most commonly available in a 0.4 mg strength as prolonged-release or sustained-release capsules
